Fundz

neuroClues closes €5M for eye-tracking device in pre-Series A funding round led by White Fund and the European Commission’s EIC Accelerator program

PRIVATEApr 30, 2024

Amount Raised

€5 Million

Round Type

Pre-Series A

Louvain-la-NeuveBiotechnologyHealth CareMedicalMedical Device

Investors

Fiona Du MonceauInvest.BwOlivier LegrainEuropean Commission’s Eic Accelerator ProgramWhite FundArtwall

Description

neuroClues has closed a €5 million pre-Series A funding round led by White Fund and the European Commission’s EIC Accelerator program, with participation from existing investors Invest.BW and business angels such as Fiona du Monceau, Artwall, and Olivier Legrain. The funding will enable the company to expand into European and North American markets and to obtain FDA approval in the United States starting in 2024 and CE marking in Europe in 2025.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as neuroClues that raised within 45 days of this round, from Fundz verified event records.

  • Hubly raised $1.3M on June 14, 2024.
  • Leo Cancer Care raised an undisclosed amount (Series C) on June 11, 2024.
  • Novocuff raised $6.8M on June 4, 2024.
  • May Health raised $25M (Series B) on May 13, 2024.
  • Nami Surgical raised $4M (Seed) on May 8, 2024.
  • Inheart raised $11M (Funding Round) on May 7, 2024.

Who to call at neuroClues, and when

A new round usually means neuroClues is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day neuroClues raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at neuroClues, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at neuroClues. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

neuroClues

Location

Louvain-la-Neuve, Wallonie, Belgium

About

neuroClues is a French-Belgian medtech startup developing a medical device based on eye-tracking to aid in the early diagnosis of neurological diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment neuroClues raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for neuroClues's next move

See what Strategic adds

neuroClues raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.